Money

Merck snags Chinese obesity drug in nearly $2 billion deal

Photo of Oklahoma Digital News Oklahoma Digital NewsDecember 19, 2024
Less than a minute



Merck will gain the exclusive global license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors. Read More


Source link

Photo of Oklahoma Digital News Oklahoma Digital NewsDecember 19, 2024
Less than a minute
Photo of Oklahoma Digital News

Oklahoma Digital News

Related Articles

Trump set to sign Laken Riley Act mandating detention of migrants accused of theft and violent crimes as his first piece of legislation

January 29, 2025

How high rates and high prices are contributing to low existing home sales

January 29, 2025

Lithuania is the world’s happiest country for young people. Here’s what it’s like to work for the country’s leading tech unicorn

January 29, 2025

Donald Trump says he wants a bidding war for TikTok and wouldn’t mind if Microsoft won

January 29, 2025

Leave a Reply

Your email address will not be published. Required fields are marked *